Olaparib 150mg tablets
NHS hospitals in England used £66,666,001 of indicative cost of Olaparib 150mg tablets in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is up 4.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Olaparib 150mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Olaparib 150mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £3,802,868 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,972,105 |
| The Royal Marsden Nhs Foundation Trust | £2,896,950 |
| Portsmouth Hospitals Nhs Trust | £1,834,349 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,830,293 |
| University College London Foundation Tr | £1,721,844 |
| Sheffield Teaching Hospitals Nhs Trust | £1,712,760 |
| East And North Hertfordshire Nhs Trust | £1,666,491 |
| Hull And East Yorkshire Hpls Nhs Trust | £1,602,013 |
| United Lincolnshire Hospitals Nhs Trust | £1,576,106 |
The primary-care picture
Olaparib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Olaparib medicine page.